Medicine and Dentistry
Breast Cancer
100%
Oncology
43%
Drug Megadose
36%
Clinical Trial
27%
Bone Marrow Transplantation
26%
Tumor Cell
24%
Transplantation
23%
Disease
23%
Liver Transplantation
21%
Stem Cell
21%
Cytomegalovirus Infection
18%
Ganciclovir
18%
Granulocyte Macrophage Colony Stimulating Factor
18%
Hematopoietic Stem Cell Transplantation
17%
Adjuvant Therapy
15%
Metastatic Breast Cancer
15%
Progenitor Cell
15%
Apheresis
15%
Mycosis
15%
Multiple Organ Dysfunction Syndrome
14%
Peripheral Blood Stem Cell
14%
Pulmonary Hemorrhage
14%
Deformity
14%
Neoplasm
12%
Peripheral Stem Cell Transplantation
12%
Autograft
12%
Stem Cell Transplant
12%
Cancer Therapy
12%
Osteoblast
11%
Hormone Therapy
11%
Nervous System Dysfunction
10%
Cytomegalovirus
10%
Metastatic Carcinoma
10%
Central Nervous System
9%
Antithrombin III
9%
Autotransplantation
9%
Cell Transplantation
9%
High Dose Chemotherapy
9%
Bacterial Infection
9%
Hematologic Malignancy
9%
Infection
8%
Cohort Effect
8%
Autologous Bone Marrow Transplantation
8%
Mononuclear Cell
8%
Radiation Therapy
7%
Acute Myeloid Leukemia
7%
Infection Control
7%
Myelodysplastic Syndrome
7%
Osteoprogenitor Cell
7%
Infectious Complication
7%
Immunology and Microbiology
Bone Marrow Transplantation
71%
Drug Megadose
48%
Cytomegalovirus
40%
Stem Cell Transplantation
38%
Peripheral Blood Stem Cell
36%
Cytomegalovirus Infection
34%
Transplant Procedure
33%
Stem Cell
27%
Granulocyte Macrophage Colony-Stimulating Factor
25%
Monocyte
22%
Intravenous Immunoglobulin
20%
Natural Killer Cell
17%
Central Nervous System
17%
Lymphocyte
15%
Liver Transplantation
14%
Cytokine
14%
T Cell
13%
Apheresis
13%
Immunocompromised Patient
13%
Granulocyte Colony-Stimulating Factor
12%
Allotransplantation
12%
Autograft
12%
Stem Cell Transplant
12%
Tumor Cell
12%
Mononuclear Cell
11%
Phytohaemagglutinin
10%
CD4
10%
Allogeneic Bone Marrow Transplantation
10%
Interleukin 2
9%
Methotrexate
9%
Granulocyte
9%
Failure Free Survival
9%
Mitogenesis
8%
Survival Rate
8%
Hematopoietic Stem Cell Transplantation
8%
Growth Factor
8%
Engraftment
8%
Leukocyte
7%
Cell Function
7%
Mortality Rate
7%
Hemopoietic Growth Factor
7%
Cell Transplantation
7%
T-Helper Cell
7%
Host
7%
Dendritic Cell Vaccine
7%
Pneumocystis Carinii
7%
Candida Krusei
7%
Titer
7%
Aspergillus
7%
Autologous Stem Cell Transplantation
7%
Keyphrases
Breast Cancer
53%
Invasive Breast Cancer
46%
Oncology
45%
Clinical Practice Guidelines
43%
NCCN Guidelines
27%
Disfigurement
19%
Physician Participation
19%
Prospective Clinical Trial
19%
Therapeutic Potential
18%
Clinical Trials
15%
Cancer Treatment
15%
Breast Cancer Treatment
15%
Clinical Situation
15%
Follow-up Recommendations
15%
Bone Marrow Transplantation
14%
Tumor Cells
14%
Multiple Organ Dysfunction Syndrome
14%
Endocrine Therapy
11%
Monocytes
10%
Early Breast Cancer
10%
Allogeneic Bone Marrow Transplantation
10%
Systemic Adjuvant Therapies
9%
Patient-physician
9%
Breast Cancer Patients
9%
Granulocyte Colony-stimulating Factor (G-CSF)
9%
Hematological Malignancies
9%
Metastatic Breast Cancer
8%
Cytomegalovirus Infection
8%
Stem Cell Products
8%
Methotrexate
8%
Ascites
7%
Disseminated Intravascular Coagulation
7%
Shunt
7%
5-year Outcomes
7%
Acyclovir
7%
Human Bone Marrow
7%
Blood Stem Cells
7%
Osteoblast Cells
7%
Immune Globulin
7%
Risk Analysis
7%
CD4+ T Cells
7%
Colon Cancer
7%
Invasive Candidiasis
7%
Immunoglobulin
7%
Growth Factors
7%
Central Nervous System Aspergillosis
7%
Randomized Prospective Trial
7%
Clinical Stage I
7%
Allogeneic Blood Stem Cell Transplantation
7%
Heparin Flush
7%